Protein & Cell >

2019 , Vol. 10 >Issue 12: 927 - 928

DOI: https://doi.org/10.1007/s13238-019-0640-1

CORRECTION

Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers

  • Yuanlong Ge 1,2 ,
  • Shu Wu 1,2 ,
  • Zepeng Zhang 1,2 ,
  • Xiaocui Li 1,2 ,
  • Feng Li 1 ,
  • Siyu Yan 1 ,
  • Haiying Liu 1,2 ,
  • Junjiu Huang 1 ,
  • Yong Zhao , 1,2
Expand
  • 1. MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yatsen University, Guangzhou 510006, China
  • 2. Collaborative Innovation Center of High Performance Computing, National University of Defense Technology, Changsha 410073, China

Published date: 15 Dec 2019

Copyright

2019 The Author(s)
Fold

Cite this article

Yuanlong Ge , Shu Wu , Zepeng Zhang , Xiaocui Li , Feng Li , Siyu Yan , Haiying Liu , Junjiu Huang , Yong Zhao . Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers[J]. Protein & Cell, 2019 , 10(12) : 927 -928 . DOI: 10.1007/s13238-019-0640-1

Options
Outlines

/

〈 〉